These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 27052366)

  • 1. COMT Val(158)Met genotype and cannabis use in people with an At Risk Mental State for psychosis: Exploring Gene x Environment interactions.
    Nieman DH; Dragt S; van Duin EDA; Denneman N; Overbeek JM; de Haan L; Rietdijk J; Ising HK; Klaassen RMC; van Amelsvoort T; Wunderink L; van der Gaag M; Linszen DH
    Schizophr Res; 2016 Jul; 174(1-3):24-28. PubMed ID: 27052366
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of childhood maltreatment and cannabis use on adult psychotic symptoms is modified by the COMT Val¹⁵⁸Met polymorphism.
    Vinkers CH; Van Gastel WA; Schubart CD; Van Eijk KR; Luykx JJ; Van Winkel R; Joëls M; Ophoff RA; Boks MP; ; Bruggeman R; Cahn W; de Haan L; Kahn RS; Meijer CJ; Myin-Germeys I; van Os J; Wiersma D
    Schizophr Res; 2013 Oct; 150(1):303-11. PubMed ID: 23954148
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Catechol-O-Methyltransferase (COMT) Val158Met variations and cannabis use in first-episode non-affective psychosis: clinical-onset implications.
    Pelayo-Terán JM; Pérez-Iglesias R; Mata I; Carrasco-Marín E; Vázquez-Barquero JL; Crespo-Facorro B
    Psychiatry Res; 2010 Oct; 179(3):291-6. PubMed ID: 20493536
    [TBL] [Abstract][Full Text] [Related]  

  • 4. COMT ValMet moderation of cannabis-induced psychosis: a momentary assessment study of 'switching on' hallucinations in the flow of daily life.
    Henquet C; Rosa A; Delespaul P; Papiol S; Fananás L; van Os J; Myin-Germeys I
    Acta Psychiatr Scand; 2009 Feb; 119(2):156-60. PubMed ID: 18808401
    [TBL] [Abstract][Full Text] [Related]  

  • 5. COMT Val158Met-stress interaction in psychosis: role of background psychosis risk.
    Collip D; van Winkel R; Peerbooms O; Lataster T; Thewissen V; Lardinois M; Drukker M; Rutten BP; Van Os J; Myin-Germeys I
    CNS Neurosci Ther; 2011 Dec; 17(6):612-9. PubMed ID: 21073668
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cannabis use and age at onset of psychosis: further evidence of interaction with COMT Val158Met polymorphism.
    Estrada G; Fatjó-Vilas M; Muñoz MJ; Pulido G; Miñano MJ; Toledo E; Illa JM; Martín M; Miralles ML; Miret S; Campanera S; Bernabeu C; Navarro ME; Fañanás L
    Acta Psychiatr Scand; 2011 Jun; 123(6):485-92. PubMed ID: 21231925
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Psychosis-inducing effects of cannabis are related to both childhood abuse and COMT genotypes.
    Alemany S; Arias B; Fatjó-Vilas M; Villa H; Moya J; Ibáñez MI; Ortet G; Gastó C; Fañanás L
    Acta Psychiatr Scand; 2014 Jan; 129(1):54-62. PubMed ID: 23445265
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Moderation of the effect of adolescent-onset cannabis use on adult psychosis by a functional polymorphism in the catechol-O-methyltransferase gene: longitudinal evidence of a gene X environment interaction.
    Caspi A; Moffitt TE; Cannon M; McClay J; Murray R; Harrington H; Taylor A; Arseneault L; Williams B; Braithwaite A; Poulton R; Craig IW
    Biol Psychiatry; 2005 May; 57(10):1117-27. PubMed ID: 15866551
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An experimental study of catechol-o-methyltransferase Val158Met moderation of delta-9-tetrahydrocannabinol-induced effects on psychosis and cognition.
    Henquet C; Rosa A; Krabbendam L; Papiol S; Fananás L; Drukker M; Ramaekers JG; van Os J
    Neuropsychopharmacology; 2006 Dec; 31(12):2748-57. PubMed ID: 16936704
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evidence that the COMT(Val158Met) polymorphism moderates sensitivity to stress in psychosis: an experience-sampling study.
    van Winkel R; Henquet C; Rosa A; Papiol S; Fananás L; De Hert M; Peuskens J; van Os J; Myin-Germeys I
    Am J Med Genet B Neuropsychiatr Genet; 2008 Jan; 147B(1):10-7. PubMed ID: 17525974
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cannabis use, COMT, BDNF and age at first-episode psychosis.
    Mané A; Bergé D; Penzol MJ; Parellada M; Bioque M; Lobo A; González-Pinto A; Corripio I; Cabrera B; Sánchez-Torres AM; Saiz-Ruiz J; Bernardo M;
    Psychiatry Res; 2017 Apr; 250():38-43. PubMed ID: 28142064
    [TBL] [Abstract][Full Text] [Related]  

  • 12. COMT Val158Met moderation of stress-induced psychosis.
    Stefanis NC; Henquet C; Avramopoulos D; Smyrnis N; Evdokimidis I; Myin-Germeys I; Stefanis CN; Van Os J
    Psychol Med; 2007 Nov; 37(11):1651-6. PubMed ID: 17640440
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetic moderation of the effects of cannabis: catechol-O-methyltransferase (COMT) affects the impact of Δ9-tetrahydrocannabinol (THC) on working memory performance but not on the occurrence of psychotic experiences.
    Tunbridge EM; Dunn G; Murray RM; Evans N; Lister R; Stumpenhorst K; Harrison PJ; Morrison PD; Freeman D
    J Psychopharmacol; 2015 Nov; 29(11):1146-51. PubMed ID: 26464454
    [TBL] [Abstract][Full Text] [Related]  

  • 14. COMT val158met and 5-HTTLPR genetic polymorphisms moderate executive control in cannabis users.
    Verdejo-García A; Fagundo AB; Cuenca A; Rodriguez J; Cuyás E; Langohr K; de Sola Llopis S; Civit E; Farré M; Peña-Casanova J; de la Torre R
    Neuropsychopharmacology; 2013 Jul; 38(8):1598-606. PubMed ID: 23449176
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Catechol-O-methyltransferase (COMT) genotype moderates the effects of childhood trauma on cognition and symptoms in schizophrenia.
    Green MJ; Chia TY; Cairns MJ; Wu J; Tooney PA; Scott RJ; Carr VJ;
    J Psychiatr Res; 2014 Feb; 49():43-50. PubMed ID: 24252819
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gene-environment interaction between an endocannabinoid system genetic polymorphism and cannabis use in first episode of psychosis.
    Bioque M; Mas S; Costanzo MC; Cabrera B; Lobo A; González-Pinto A; Rodriguez-Toscano E; Corripio I; Vieta E; Baeza I; Ibáñez Á; Fraile MG; Cuesta MJ; Mezquida G; Lafuente A; Bernardo M;
    Eur Neuropsychopharmacol; 2019 Jun; 29(6):786-794. PubMed ID: 31076188
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Catechol-O-methyltransferase gene methylation and substance use in adolescents: the TRAILS study.
    van der Knaap LJ; Schaefer JM; Franken IH; Verhulst FC; van Oort FV; Riese H
    Genes Brain Behav; 2014 Sep; 13(7):618-25. PubMed ID: 24902721
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interaction between COMT haplotypes and cannabis in schizophrenia: a case-only study in two samples from Spain.
    Costas J; Sanjuán J; Ramos-Ríos R; Paz E; Agra S; Tolosa A; Páramo M; Brenlla J; Arrojo M
    Schizophr Res; 2011 Apr; 127(1-3):22-7. PubMed ID: 21310591
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of Single Nucleotide Polymorphisms in Catechol-O-Methyltransferase and Serine-Threonine Protein Kinase Genes in the Pakistani Schizophrenic Population: A Study with Special Emphasis on Cannabis and Smokeless Tobacco.
    Nawaz R; Siddiqui S
    CNS Neurol Disord Drug Targets; 2015; 14(8):1086-95. PubMed ID: 25801838
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The relationship between catechol-O-methyltransferase gene Val158Met (COMT) polymorphism and premorbid cannabis use in Turkish male patients with schizophrenia.
    Ermis A; Erkiran M; Dasdemir S; Turkcan AS; Ceylan ME; Bireller ES; Cakmakoglu B
    In Vivo; 2015; 29(1):129-32. PubMed ID: 25600541
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.